Best Podium and Poster Presentations Awarded at ISPOR 22nd Annual International Meeting

Boston, MA—May 24, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized the Best Podium and Poster Presentation Awardees at its 22nd Annual International Meeting today in Boston, MA, USA. The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations at ISPOR’s Annual International Meetings, Annual European Congresses, Asia-Pacific Conferences, and Latin America Conferences.

BEST PODIUM PRESENTATION AWARDS

Best General Podium Presentation Awards

  • Stephen S Johnston, Johnson & Johnson Co., New Brunswick, NJ, USA
    MD4: COMPARISON OF ECONOMIC AND CLINICAL OUTCOMES BETWEEN THE DERMABOND® PRINEO® SKIN CLOSURE SYSTEM AND SKIN STAPLES IN PATIENTS UNDERGOING KNEE REPLACEMENT IN REAL WORLD CLINICAL PRACTICE
  • Kristina Secnik Boye, PhD, RPh, BS, MS, MPH, Eli Lilly and Company, Indianapolis, IN, USA
    PP4: VALIDATION OF A QUESTIONNAIRE TO ASSESS PATIENT PERCEPTIONS OF INJECTION DEVICES FOR TYPE 2 DIABETES
  • Frank Xiaoqing Liu, Merck and Co., Inc., North Wales, PA, USA
    PP1: COMPARISON OF PATIENT, ONCOLOGIST, AND ONCOLOGY NURSE PREFERENCES FOR ATTRIBUTES OF DRUG THERAPY IN ADVANCED MELANOMA

Best Student Podium Presentation Awards

  • Rahul Garg, West Virginia University, Morgantown, WV, USA CN2: IMPACT OF DIFFUSE LARGE B-CELL LYMPHOMA ON VISITS TO DIFFERENT PROVIDER SPECIALTIES AMONG ELDERLY MEDICARE BENEFICIARIES: CHALLENGES FOR CARE COORDINATION
  • Weihsuan Lo-Ciganic, PhD, MS, MSPharm, University of Arizona, Tucson, AZ, USA TP4: GEOGRAPHIC VARIATION OF INAPPROPRIATE PRESCRIPTION OPIOID USE AMONG DISABLED MEDICARE BENEFICIARIES
  • Yingnan Zhao, PhD, Xavier University of Louisiana, New Orleans, LA, USA DB2: RACIAL DISPARITY IN ACCESS TO NEWER CLASS ANTI-DIABETICS AMONG ADULT PATIENTS WITH DIABETES IN THE U.S.

Best New Investigator Podium Research Presentations

  • Lindsey A. Falk, Health Quality Ontario, Toronto, ON, USA
    MD1: COST EFFECTIVENESS OF THE LEFT ATRIAL APPENDAGE CLOSURE DEVICE COMPARED WITH ORAL ANTICOAGULANTS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
  • Janki S. Bhatt, PhD, Cigna Health and Life Insurance Company, Bloomfield, CT, USA
    AD3: IMPACT OF MEDICATION ADHERENCE ON TOTAL MEDICAL COSTS
  • Chia-Te Liao, Chimei Medical Center, Tainan, Taiwan
    CV2: ECONOMIC EVALUATION OF ALTERNATIVE ANTICOAGULANT DRUGS FOR THE PREVENTION OF STROKE AMONG 65-YEAR OLD ATRIAL FIBRILLATION PATIENTS IN TAIWAN

BEST POSTER PRESENTATION AWARDS

Best General Poster Research Presentations

  • Donatus (Don) Ekwueme, US CDC, Atlanta, GA, USA
    PIH22: ESTIMATION OF BREAST CANCER INCIDENT CASES AND MEDICAL CARE COSTS ATTRIBUTABLE TO ALCOHOL CONSUMPTION AMONG INSURED WOMEN UNDER AGE 45 YEARS IN THE UNITED STATES
  • Lori McLeod, RTI Health Solutions, Research Triangle Park, NC, USA
    PDB68: PSYCHOMETRIC EVALUATION OF THE NV QUESTIONNAIRE IN PATIENTS WITH T2DM RECEIVING A GLP-1 AGONIST
  • Yu Shen, UT MD Anderson Cancer Center, Houston, TX, USA
    PCN254: DO ADVANCES IN BREAST CANCER TREATMENT RENDER SCREENING MAMMOGRAPHY NOT COST-EFFECTIVE FOR AVERAGE-RISK WOMEN?

Best Student Poster Research Presentations

  • Arun Kumar, St. John’s University, New York, NY, USA
    PCV16: FONDAPARINUX SODIUM COMPARED WITH LOW MOLECULAR WEIGHT HEPARINS FOR THROMBOPROPHYLAXIS AMONG PATIENTS AT RISK AS PER VIRCHOW’S TRIAD: A SYSTEMATIC REVIEW AND META ANALYSIS
  • Pratik Rane, University of Houston, TX, USA
    PGI1: RISK OF CLOSTRIDIUM DIFFICILE INFECTION ASSOCIATED WITH PROTON PUMP INHIBITOR USE AMONG COMMUNITY DWELLING ADULTS WITH GASTROESOPHAGEAL REFLUX DISEASE
  • Nibu Parameswaran Nair, University of Tasmania, Hobart, Australia
    PIH4: REPEAT ADVERSE DRUG REACTION-RELATED HOSPITAL ADMISSIONS IN ELDERLY AUSTRALIANS

Best New Investigator Poster Research Presentations

  • Mayank R. Ajmera, RTI Health Solutions, Research Triangle Park, NC, USA
    PND25: INCREMENTAL ECONOMIC BURDEN OF CARDIOMETABOLIC DISORDERS AMONG PATIENTS WITH EPILEPSY
  • Tim Wiltshire, University of North Carolina, Chapel Hill, NC, USA
    PCV95: PROJECTED IMPACT OF ADOPTING A MULTIPLEXED PREEMPTIVE GENOTYPING INTERVENTION IN CARDIAC CATHETERIZATION LABORATORY PATIENTS
  • Sandipan Bhattacharjee, University of Arizona, Tucson, AZ, USA
    PCN79: HEALTHCARE EXPENDITURES AMONG COMMUNITY-DWELLING ADULTS WITH THYROID CANCER IN THE UNITED STATES: A PROPENSITY SCORE MATCHED ANALYSIS

Additional information on the ISPOR 22nd Annual International Meeting can be found here. Released presentations from the conference can be found here. Interested parties can follow news at ISPOR’s press site and on social media using the conference hashtag #ISPORBoston.

###

 

ABOUT ISPOR
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally.
Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

 

 

Posted in Announcements, ISPOR News & Press Tagged with: ,